Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 5
1991 13
1992 82
1993 91
1994 107
1995 88
1996 81
1997 77
1998 95
1999 102
2000 119
2001 113
2002 139
2003 151
2004 141
2005 158
2006 170
2007 193
2008 239
2009 264
2010 303
2011 314
2012 362
2013 386
2014 443
2015 474
2016 411
2017 447
2018 383
2019 232
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

5,613 results
Results by year
Filters applied: . Clear all
Page 1
DEB-TACE: a standard review
Melchiorre F, et al. Future Oncol 2018 - Review. PMID 29987957
Drug-eluting bead transarterial chemoembolization (DEB-TACE) is a relative new endovascular treatment based on the use of microspheres to release chemotherapeutic agents within a target lesion with controlled pharmacokinetics. ...
Drug-eluting bead transarterial chemoembolization (DEB-TACE) is a relative new endovascular treatment based on the use of microsphere …
Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence
Raoul JL, et al. Cancer Treat Rev 2019 - Review. PMID 30447470
According to the Barcelona Clinic Liver Cancer (BCLC) staging system, transarterial chemoembolization (TACE) is the first-line treatment for patients with intermediate stage HCC, including those with large or multinodular HCC, well-preserved liver function, and no cancer-related symptoms or evidence of vascular invasion or extrahepatic spread. ...
According to the Barcelona Clinic Liver Cancer (BCLC) staging system, transarterial chemoembolization (TACE) is the first-line treatm …
Efficacy and Safety of Transarterial Chemoembolization Plus External Beam Radiotherapy vs Sorafenib in Hepatocellular Carcinoma With Macroscopic Vascular Invasion: A Randomized Clinical Trial.
Yoon SM, et al. JAMA Oncol 2018 - Clinical Trial. PMID 29543938 Free PMC article.
Combined treatment with transarterial chemoembolization (TACE) plus external beam radiotherapy (RT) has shown promising results for these patients in observational studies. ...
Combined treatment with transarterial chemoembolization (TACE) plus external beam radiotherapy (RT) has shown promising results for t …
Drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma: Current state of the art.
Facciorusso A. World J Gastroenterol 2018 - Review. PMID 29375202 Free PMC article.
Transarterial chemoembolization (TACE) represents the current gold standard for hepatocellular carcinoma (HCC) patients in intermediate stage. ...
Transarterial chemoembolization (TACE) represents the current gold standard for hepatocellular carcinoma (HCC) patients in intermedia …
Transarterial chemoembolization: modalities, indication, and patient selection.
Sieghart W, et al. J Hepatol 2015 - Review. PMID 25681552 Free article.
Transarterial chemoembolization (TACE) is the standard of care for patients with intermediate stage hepatocellular carcinoma (BCLC B). ...
Transarterial chemoembolization (TACE) is the standard of care for patients with intermediate stage hepatocellular carcinoma (BCLC B) …
Transarterial chemoembolization in hepatocellular carcinoma with portal vein tumor thrombosis: a systematic review and meta-analysis.
Silva JP, et al. HPB (Oxford) 2017 - Review. PMID 28552299 Free article.
BACKGROUND: Transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC) with portal vein thrombosis (PVT) remains controversial. ...METHODS: PubMed was searched for "hepatocellular carcinoma" and "transarterial chemoembolization" from January 1, 2006 to August 31, 2016. ...
BACKGROUND: Transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC) with portal vein thrombosis (PVT) remains contr …
Comparative efficacy of treatment strategies for hepatocellular carcinoma: systematic review and network meta-analysis
Tian G, et al. BMJ Open 2018. PMID 30341113 Free PMC article.
METHODS AND ANALYSES: We pooled the OR for 1-year, 3-year and 5-year overall survival, based on lesions of size ˂ 3 cm, 3-5 cm and ≤5 cm, using five therapeutic options including resection (RES), radiofrequency ablation (RFA), microwave ablation (MWA), transcatheter arterial chemoembolisation (TACE) plus RFA (TR) and percutaneous ethanol injection (PEI). ...
METHODS AND ANALYSES: We pooled the OR for 1-year, 3-year and 5-year overall survival, based on lesions of size ˂ 3 cm, 3-5 cm and ≤5 cm, us …
Complications of transarterial chemoembolization (TACE) in the treatment of liver tumors.
Marcacuzco Quinto A, et al. Cir Esp 2018. PMID 30082086
INTRODUCTION: Transarterial chemoembolization (TACE) is considered a therapeutic option. It is mostly used in hepatocellular carcinoma or liver colorectal, neuroendocrine or melanoma metastases. ...Major complications after chemoembolization included: decompensation with edema/ascites (6patients), acute cholecystitis (4), acute pancreatitis (3), liver rupture (1), liver abscess (1) and renal failure (1). ...
INTRODUCTION: Transarterial chemoembolization (TACE) is considered a therapeutic option. It is mostly used in hepatocellular carcinom …
5,613 results
Jump to page
Feedback